General Information of Drug (ID: DMB6XUY)

Drug Name
CL-205086 Drug Info
Synonyms
Imidazole, 4-nitro-; PubChem7615; VYDWQPKRHOGLPA-UHFFFAOYSA-N; Y8U32AZ5O7; 100214-79-7; 1H-4-Nitroimidazole; 1H-5-Nitroimidazole; 1H-Imidazole, 4-nitro-; 1H-Imidazole, 5-nitro-; 3034-38-6; 4(5)-Nitroimidazole; 4-NITRO-1H-IMIDAZOLE; 4-Nitroimidazole; 4-Nitroimidazole, 97%; 4-Nitroimidazole, 98%; 4-nitro-3H-imidazole; 4-nitro-imidazole; 5(4)-nitroimidazole; 5-Nitro-1H-imidazole; 5-Nitroimidazole; 88054-21-1; ACMC-1AIMC; AI3-60154; CHEBI:64635; EC 221-224-7; EINECS 221-224-7; MFCD00005196; NSC 50359; UNII-Y8U32AZ5O7
Indication
Disease Entry ICD 11 Status REF
Intestinal amebiasis 1A36 Investigative [1]
Cross-matching ID
PubChem CID
18208
ChEBI ID
CHEBI:64635
CAS Number
CAS 3034-38-6
TTD Drug ID
DMB6XUY
INTEDE Drug ID
DR2214

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AI3-23606 DMHMT49 Trypanosomiasis 1D51-1F53 Phase 1 [2]
2-chloro-5-nitro-N-phenylbenzamide DMUGQIV Discovery agent N.A. Investigative [3]
Nitroimidazole DMMY2S5 Trypanosomiasis 1D51-1F53 Investigative [2]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ornidazole DM6QHDJ Amoebiasis 1A36 Approved [4]
Nitrazepam DMEGIQ6 Epilepsy 8A60-8A68 Approved [4]
AI3-23606 DMHMT49 Trypanosomiasis 1D51-1F53 Phase 1 [2]
2-chloro-5-nitro-N-phenylbenzamide DMUGQIV Discovery agent N.A. Investigative [3]
Nitroimidazole DMMY2S5 Trypanosomiasis 1D51-1F53 Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Oxygen-insensitive NADPH nitroreductase A (nfsA) DEX5D46 NFSA_SALTY Substrate [2]
Oxygen-insensitive NADPH nitroreductase B (nfsB) DEOWDK1 NFSB_SALTY Substrate [2]

References

1 Nitroimidazole-containing compounds and their antibacterial and antitubercular activities. Eur J Med Chem. 2019 Oct 1;179:376-388.
2 Delamanid is not metabolized by Salmonella or human nitroreductases: a possible mechanism for the lack of mutagenicity. Regul Toxicol Pharmacol. 2017 Mar;84:1-8.
3 Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability. Chem Biol Interact. 2012 Apr 15;197(1):16-22.
4 Identification and characterization of SnrA, an inducible oxygen-insensitive nitroreductase in Salmonella enterica serovar Typhimurium TA1535. Mutat Res. 2002 Oct 31;508(1-2):59-70.